Cervical cancer (over)screening in Belgium and Switzerland: trends and social inequalities
- 10 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 30 (3) , 552-557
Abstract
Background: Cervical cancer screening (CCS) by means of Pap smears has led to a decrease in cervical cancer incidence and mortality. In the absence of organized programmes, CCS is opportunistic in Belgium and Switzerland. This might result in a high level of CCS overuse, as screening practices do not conform to the recommended 3-yearly screening interval and the target age-ranges (Belgium: 25–64, Switzerland: 20–70). This study aimed to assess trends in CCS uptake and overuse in Belgium and Switzerland and their social determinants, in the light of reimbursement initiatives, which were implemented in both countries. Methods: Data from five waves of the Belgian Health Interview Survey (1997–2013) (N=11 141) and Swiss Health Interview Survey (1992–2012) (N=32 696) were used. We performed Poisson regressions to estimate adjusted prevalence ratios (APR), controlled for socio-economic and socio-demographic characteristics and health status. CCS overuse was operationalized as screening more than once every 3 years and screening above recommended age-range. Results: CCS uptake remained relatively stable over time, with a mean coverage of 70.9% in Belgium and 73.1% in Switzerland. Educational and income gradients were found in both countries. Concerning CCS overuse, women above screening-eligible age showed consistently high screening rates, but screening within the past year declined significantly in both countries, matching the temporal implementation of the reimbursement initiatives. Conclusions: Although no increase in CCS coverage could be established, CCS has become more efficient in both countries as Pap smear overuse at the population level has declined after the implementation of reimbursement measures tackling CCS overuse.Keywords
Funding Information
- Fonds Wetenschappelijk Onderzoek (FWOOPR2018005701)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (176115)
This publication has 31 references indexed in Scilit:
- European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition—Summary DocumentAnnals of Oncology, 2010
- Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening programInternational Journal of Epidemiology, 2010
- Trends of cervical cancer mortality in the member states of the European UnionEuropean Journal of Cancer, 2009
- The challenges of organising cervical screening programmes in the 15 old member states of the European UnionEuropean Journal of Cancer, 2009
- Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996–2000)Preventive Medicine, 2009
- Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in BelgiumCancer Epidemiology, Biomarkers & Prevention, 2009
- Who receives, benefits from and is harmed by cervical and breast cancer screening among Hong Kong Chinese?Journal of Public Health, 2008
- Guideline zum Vorgehen bei suspektem und positivem zytologischen Abstrich der Cervix uteri (überarbeitete Fassung, Version 2.4)Gynäkologisch-geburtshilfliche Rundschau, 2004
- Cervical cancer mortality in young women in EuropeEuropean Journal of Cancer, 2000
- Cervical cancer screening in the Flemish region (Belgium): measurement of the attendance rate by telephone interviewEuropean Journal Of Cancer Prevention, 1997